Helix BioPharma Corp. (TSE:HBP – Get Free Report)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.93 and traded as high as C$0.98. Helix BioPharma shares last traded at C$0.98, with a volume of 5,000 shares traded.
Helix BioPharma Price Performance
The stock has a market capitalization of C$51.96 million, a price-to-earnings ratio of -1.03 and a beta of -0.84. The company’s 50-day simple moving average is C$0.93 and its 200 day simple moving average is C$0.96.
About Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Further Reading
- Five stocks we like better than Helix BioPharma
- Upcoming IPO Stock Lockup Period, Explained
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- DuPont’s Electronics Spinoff: The Start of Something Big
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}